 |
|
Biotech News
PRESS RELEASE ARCHIVES FROM SEND2PRESS® NEWSWIRE
NOTICE: THIS IS ARCHIVAL CONTENT AND LIKELY OUT OF DATE.
Edited for Send2Press by Carly Zander
Health Discovery Corporation Announces Agreement With M.D. Anderson Cancer Center for Biomarker and Pathway Discovery in Prostate Cancer
WACO, Texas - Jan. 26, 2004 /Send2Press Newswire/ -- Health Discovery Corporation (OTC
Bulletin Board: HDVY) today announced the signing of its second Biomarker and Pathway
Discovery Agreement with The University of Texas, M.D. Anderson Cancer Center in Houston
Texas. Under the terms of the Agreement, The University of Texas, M.D. Anderson Cancer
Center, has granted the Company a first option to obtain an exclusive worldwide royalty-
bearing commercial license to commercialize any discovered prostate cancer biomarkers or
pathways identified by the Company utilizing its proprietary and patent protected Fractal
Genomics Modeling (FGM) techniques.
For the third time in four years, The University of Texas M.D. Anderson Cancer Center is
ranked the nation's top cancer hospital in U.S. News and World Report's "America's Best
Hospitals" survey, published in the magazine's July 28 2003 issue.
Stephen D. Barnhill, M.D., Chairman and Chief Executive Officer of Health Discovery
Corporation stated, "We are honored that our Company was again selected by the Physicians and
Clinical Scientists at M.D. Anderson Cancer Center to utilize our unique approach to systems
biology to discover new patterns of biomarkers and pathways associated with prostate cancer."
Dr. Barnhill continued, "we look forward to working closely with these world renowned experts
at M.D. Anderson Cancer Center to analyze, discover, patent protect, and commercialize our
findings in the diagnosis and treatment of prostate cancer."
Dr. Herbert Fritsche, Professor and Chief of Clinical Chemistry, at M.D. Anderson Cancer
Center said, "This second collaboration with Health Discovery Corporation will give us access
to a new systems biology approach for data analysis that will lead to new biomarker and
pathway discovery in prostate cancer. We hope to use the findings of this study to develop
new diagnostic approaches for prostate cancer and improve the clinical management of these
patients."
U.S. Cancer Statistics: 2000 Incidence recently released by the Department of Health and
Human Services (HHS) shows that prostate cancer is the leading cancer overall in men in the
United States and according to the National Institutes of Health, in 1997, the estimated
number of new cases of prostate cancer in the United States alone is 209,900, and the
estimated number of deaths from this disease is 41,800.
Health Discovery Corporation is a systems biology oriented biomarker and pathway discovery
company, which uses proprietary advanced mathematical platforms, such as Fractal Genomics
Modeling (FGM) techniques, to help identify and characterize diagnostic targets and
therapeutic candidates. Focusing on disease vs. normal, within complex genomic, proteomic and
clinical data sets, Health Discovery Corporation was established to provide pharmaceutical
and diagnostic companies with a broad range of analytical and decision support solutions to
accelerate effective diagnostic and drug discovery. Founded in September 2003, the Company
has offices in Texas, Georgia, and California. For more information contact Robert S.
Braswell IV of Health Discovery Corporation +1-866-953-9031 or Info@dwcell.com.
• Previous News from Health Discovery Corporation
Jan. 8, 2004
Health Discovery Corporation Releases Shareholder Letter
Jan. 2, 2004
Health Discovery Corporation Completes the Acquisition of Fractal Genomics
Nov. 25, 2003
Dr. Tin-Chuen Yeung Named To Health Discovery Corporation Scientific Advisory Board
Nov. 14, 2003
Health Discovery Corporation, Inc. Announces the Appointment of Joe Fanelli to the Management Team as Director of Corporate Development
Nov. 6, 2003
Dr. Bernhard Scholkopf, Max Plank Director, Named To Health Discovery Corporation Scientific Advisory Board
Nov. 6, 2003
Direct Wireless Communications Inc. Announces Name Change To Health Discovery Corporation
Nov. 3, 2003
Direct Wireless Communications, Inc. Announces The Appointment Of David Cooper, M.D., Ph.D. To The Board Of Directors And The Management Team
Oct. 31, 2003
Direct Wireless Communications, Inc. Announces Agreement With Md Anderson Cancer Center For Cancer Discovery
Oct. 27, 2003
Direct Wireless Communications, Inc. Announces Board And Management Changes
Oct. 2, 2003
Ramananda K. Madyastha, M.D., Ph.D., Award Winning Cancer Researcher Named To Direct Wireless Communications Scientific Advisory Board
Oct. 2, 2003
Ramananda K. Madyastha, M.D., Ph.D., Award Winning Cancer Researcher Named To Direct Wireless Communications Scientific Advisory Board
Sept. 25, 2003
Direct Wireless Completes Acquisition Of The Barnhill Group
Sept. 18, 2003
Direct Wireless Communications Hosts Reception For 15th Annual Genomic Sequencing And Analysis Conference Held By The Institute For Genomic Research (Tigr) In Savannah, Georgia
Sept. 9, 2003
Dr. Kary Mullis, Nobel Prize Winning Chemist Named To Direct Wireless Communications Scientific Advisory Board
Sept. 3, 2003
Dr. Herbert Fritsche Presents Cancer Discovery At International Cancer Meeting
Sept. 2, 2003
Direct Wireless Enters Into A Letter Of Agreement To Acquire Fractal Genomics
August 26, 2003
Direct Wireless Enters Into A Letter Of Agreement To Acquire The Barnhill Group
FOR INFORMATION ABOUT THE COMPANY OR ORGANIZATION(S) MENTIONED IN THE ABOVE BUSINESS NEWS ARTICLE, PLEASE CONTACT THE COMPANY DIRECTLY AND NOT THIS WEBSITE.
DISCLAIMER: the above business news article is believed accurate but not guaranteed, and is based on business news supplied by the company or organization mentioned and/or quoted in the story. Financial/Stock news may contain forward looking statements and public companies should be thoroughly researched before considering material investment. Neotrope/Send2Press makes no claims of accuracy or suitability for any purpose. Any opinions expressed by representatives of company(s) mentioned in news item are solely those of the person indicated, and do not reflect any opinion or policy of Neotrope/Send2Press. Your use of any information contained herein is done solely at your own risk, and you are fully responsible for using any information herein, or on sites mentioned or linked to in the article.
USE OF THE ABOVE NEWS ARTICLE
Article is Copr. © 2004 Neotrope/Send2Press. Reproduction of this news article in any form requires written authorization. You may freely link to this article. For more information on using this article in print or on your website, please visit:
www.freeNewsArticles.com™.
|
|
|
|
Add Our News Headlines to Your Website Free
Free headline feed
Journalists & Editors
Choose your news by
preferred topic(s).
Privacy protected.
MORE INFO
Archived Releases
Most Recent Releases
NOTICE: THIS PAGE IS ARCHIVAL CONTENT AND SHOULD NOT BE RELIED UPON FOR ACCURACY.
|
|
|
